AI Platform (AIP001)

AI Platform (AIP001) is an FDA 510(k)-cleared medical device (K232501) manufactured by Exo, Inc.. This device is classified under the Radiology specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on November 16, 2023. Regulation: 8.